NEWS
Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
Allurion Technologies (NYSE: ALUR) has expanded its AI-powered weight loss coach, Coach Iris, to support patients on GLP-1s and other anti-obesity medications. This enhancement provides 24/7 personalized coaching on treatment duration, side effects, and lifestyle modifications. In addition, the company announced its first commercial agreements for its Virtual Care Suite (VCS) in the U.S.
The VCS integrates remote patient monitoring, predictive analytics, telehealth, and care team collaboration, and is designed for healthcare providers offering various weight loss therapies. Medical professionals like Dr. Christopher McGowan and Dr. Alexander Shapsis have adopted VCS, praising its ability to deliver personalized care and improve patient engagement.
According to Blue Cross Blue Shield, a substantial portion of patients discontinue GLP-1s prematurely, underscoring the need for better patient management. An Allurion study found that the VCS improved patient accountability, practice efficiency, and engagement.
The VCS integrates remote patient monitoring, predictive analytics, telehealth, and care team collaboration, and is designed for healthcare providers offering various weight loss therapies. Medical professionals like Dr. Christopher McGowan and Dr. Alexander Shapsis have adopted VCS, praising its ability to deliver personalized care and improve patient engagement.
According to Blue Cross Blue Shield, a substantial portion of patients discontinue GLP-1s prematurely, underscoring the need for better patient management. An Allurion study found that the VCS improved patient accountability, practice efficiency, and engagement.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment